Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma

Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma

Abstract The objective of this study was to investigate the clinical significance and roles of tumor progression locus 2 (TPL2) and peptidyl-prolyl cis–trans isomerase 1 (Pin1) in the occurrence and development of breast invasive ductal carcinoma (IDC). Immunohistochemistry was used to detect the ex...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Qin Yu, Dan Wan, Rong Fu, Feng Li, Yutao Zhang
Format:	Artykuł
Język:	English
Wydane:	Nature Portfolio 2023-10-01
Seria:	Scientific Reports
Dostęp online:	https://doi.org/10.1038/s41598-023-44660-z

Podobne zapisy

Schirrous invasive ductal carcinoma of the breast overexpress p53 oncoprotein
od: Flávia Silva Ferrini, i wsp.
Wydane: (2001-01-01)

The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis
od: Yun Wu, i wsp.
Wydane: (2017-12-01)

UPAR Overexpression Could Be a Potential Favorable Prognostic Marker in Invasive Ductal Carcinoma of Breast
od: Ata Abbasi, i wsp.
Wydane: (2022-06-01)

DCIS (Ductal carcinoma in situ)-like invasive ductal carcinoma of the breast
od: Huanyu Zhao, i wsp.
Wydane: (2022-10-01)

Different distribution of breast ductal carcinoma <it>in situ</it>, ductal carcinoma <it>in situ</it> with microinvasion, and invasion breast cancer
od: Wei Zhang, i wsp.
Wydane: (2012-12-01)

Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies
od: Feng Ye, i wsp.
Wydane: (2020-06-01)

Transglutaminase 2 overexpression in tumor stroma identifies invasive ductal carcinomas of breast at high risk of recurrence.
od: Jasmeet Assi, i wsp.
Wydane: (2013-01-01)

Predictors of Invasive Breast Cancer in Ductal Carcinoma In Situ Initially Diagnosed by Core Biopsy
od: Mun Yew Patrick Chan, i wsp.
Wydane: (2010-04-01)

INVASIVE CYSTIC HYPERSECRETORY DUCTAL CARCINOMA of THE BREAST
od: Erdinç Kamer, i wsp.
Wydane: (2008-04-01)

Educational Case: Invasive Ductal Carcinoma of the Breast
od: Ashley Rose Scholl MSc, i wsp.
Wydane: (2020-01-01)

Mast cells in invasive ductal breast carcinoma
od: Mitra Heidarpour, i wsp.
Wydane: (2008-10-01)

Coexistence of invasive ductal breast carcinoma and fibroadenoma
od: Fatma Saadallah, i wsp.
Wydane: (2019-06-01)

The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.
od: Ruwaa I Mohamed, i wsp.
Wydane: (2021-01-01)

Prognosis of invasive micropapillary carcinoma versus invasive ductal carcinoma of the breast: a comparative analysis after propensity score matching
od: CHEN Yuanyuan, YE Xin, TANG Yongzhe, WANG Jie, HE Qi
Wydane: (2021-07-01)

The roles of TPL in hematological malignancies
od: Tingyun Xu, i wsp.
Wydane: (2023-12-01)

A case of male breast encapsulated papillary carcinoma with ductal carcinoma in situ and invasive ductal carcinoma
od: Fangcheng Hong, i wsp.
Wydane: (2023-09-01)

Identification of aberrant gene expression during breast ductal carcinoma progression to invasive ductal carcinoma
od: Guiqin Song, i wsp.
Wydane: (2020-01-01)

Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast
od: Atif Ali Hashmi, i wsp.
Wydane: (2018-07-01)

Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
od: Akemi Morikawa, i wsp.
Wydane: (2015-01-01)

X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma
od: Peng Bofang, i wsp.
Wydane: (2011-06-01)

High expression of Rac1 is correlated with partial reversed cell polarity and poor prognosis in invasive ductal carcinoma of the breast
od: Bingbing Liu, i wsp.
Wydane: (2017-06-01)

Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma.
od: Watson, P, i wsp.
Wydane: (2003)

Importance of microcalcifications in mammographic differentiation of the invasive ductal breast cancer and of the ductal carcinoma in situ
od: Šarac Vanja, i wsp.
Wydane: (2017-01-01)

Evaluation of Immunohistochemistry Technique in Detecting HER2 Overexpression in Invasive Ductal Breast Carcinoma Using Fluorescence in-situ Hybridization Method
od: Azar Baradaran, i wsp.
Wydane: (2016-03-01)

Primary squamous cell carcinoma complicated with invasive ductal carcinoma of breast
od: Chen Fan, i wsp.
Wydane: (2025-03-01)

Medullary Breast Carcinoma and Invasive Ductal Carcinoma: A Review Study
od: Vahid Zangouri, i wsp.
Wydane: (2018-07-01)

Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma
od: A.F. Logullo, i wsp.
Wydane: (2002-08-01)

P210 Radiological and pathological predictors of post-operative upstaging to invasive ductal carcinoma and lymph nodes metastasis in patients preoperatively diagnosed with breast ductal carcinoma in situ
od: M. Pellicciaro, i wsp.
Wydane: (2023-03-01)

P-cadherin and CD10 Expression to Distinguish between Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast
od: Kanet Kanjanapradit, i wsp.
Wydane: (2019-02-01)

Association of clinico-pathological and immunohistochemical prognostic parameters with presence of ductal carcinoma in-situ in an invasive ductal carcinoma of breast
od: Dhivya Balaiya, i wsp.
Wydane: (2023-12-01)

sFRP1 expression in invasive breast ductal carcinoma.
od: Ong, Daphne Jie Lyn.
Wydane: (2010)

Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast
od: Nagwa Abd El-Sadek Ahmed, i wsp.
Wydane: (2022-02-01)

Autoamputation of the Breast in Invasive Ductal Carcinoma: A Case Report
od: Olusola-Bello MA, i wsp.
Wydane: (2022-09-01)

Prognostic Significance of Microvessel Density in Invasive Ductal Carcinoma of Breast
od: Ata Abbasi, i wsp.
Wydane: (2023-04-01)

Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
od: Zheling Chen, i wsp.
Wydane: (2017-01-01)

Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population‐based study from China
od: Ding‐yuan Wang, i wsp.
Wydane: (2023-04-01)

A case of renal cell carcinoma metastasizing to invasive ductal breast carcinoma
od: Tai-Di Chen, i wsp.
Wydane: (2014-02-01)

The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma
od: San-Gang Wu, i wsp.
Wydane: (2020-12-01)

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
od: Milim Kim, i wsp.
Wydane: (2020-03-01)

Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis
od: Xiaolu Yang, i wsp.
Wydane: (2023-11-01)